Researchers at the University of Toronto see a future where a single injection under the eyelid could replace months of daily ...

An enzyme called cyclin-dependent kinase 2 (CDK2) regulates the cell cycle and may have the potential to drive therapeutic ...

Reports of impending layoffs, a buyout offer, and a return-to-office mandate have put a damper on FDA staff morale ...

Gut bacteria are to blame for the failure of immune checkpoint therapy for ovarian cancer, new research reveals.

Genomic cancer predisposition tests should be done with professional counseling, and the FDA should implement safeguards for ...